Veteran scientist Hideo Makimura, M.D., Ph.D., is going fully preclinical by joining gene therapy biotech Affinia Therapeutics as chief medical officer. Makimura most recently served in leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback